SUBSCRIBE
SUBSCRIBE
News   Drug Development

Mesoblast Limited Interview With MD Silviu Itescu On Angioblast - Progression of Four Phase 2 Trial Applications

September 1, 2009 | 
1 min read
Melbourne, Sep 1, 2009 (ABN Newswire) - Mesoblast Limited (ASX:MSB)(PINK:MBLTY) is pleased to provide an interview with MD Silviu Itescu on its United States-based associate company Angioblast Systems Inc.
Clinical research Phase 2 Asia Australia
MORE ON THIS TOPIC
GLP-1 weighloss pills - five pills in a row on blue background with harsh lighting - orthographic perspective
Weight loss
Novo Nordisk starts trialing lower maintenance doses of oral Wegovy
August 21, 2026
 · 
2 min read
 · 
Nick Paul Taylor
pour-watered from the watering can banknotes dollars on a white background. Concept, investment, start-up business, startup, income growth.
Manufacturing
Roche pours $750M into Oregon manufacturing plant as obesity push expands
August 20, 2026
 · 
1 min read
 · 
Gabrielle Masson
Business competitive advantage of paper plane in new competitive, competitor individual pointing in different ways for new competitive advantage on 3D render. Advantage for new idea competition.
IPO
Scribe’s early-stage IPO standout defies biotech’s derisking trend
August 20, 2026
 · 
3 min read
 · 
Gabrielle Masson
Pictured: Rare disease ribbon with cut-outs of people
Rare diseases
Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
August 20, 2026
 · 
2 min read
 · 
Nick Paul Taylor